Clinical trial
A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
NCT00095758 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Development & Commercialization, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 1, 2004
- Completion date
- December 1, 2006
- Enrollment
- 1,151 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.